Live Breaking News & Updates on Dan eramian

Stay updated with breaking news from Dan eramian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HighField Biopharmaceuticals HF1K16 Phase 1a Data Suggests the New Immuno-Oncology Drug is Safe, Well-Tolerated and Efficacious in Solid Tumors

HANGZHOU, China (BUSINESS WIRE) Jan 8, 2024 ....

Hangzhou , Zhejiang , China , Dan-eramian , Donald-wyatt , Yuhong-xu , Business-development-contact , Opus-biotech-communications , Field-biopharmaceuticals , Media-contact , Development-contact , Business-wire

HighField Biopharmaceuticals Receives US FDA IND Clearance for Phase 1 Trial of Immunoliposome HF158K1 for Treatment of HER2 low and HER2+ Cancers

HighField Biopharmaceuticals Receives US FDA IND Clearance for Phase 1 Trial of Immunoliposome HF158K1 for Treatment of HER2 low and HER2+ Cancers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , Hangzhou , Zhejiang , Dan-eramian , Yuhong-xu , Donald-wyatt , Highfield-bio , Business-development-contact , Opus-biotech-communications , Drug-administration , Field-biopharmaceuticals , Investigational-new-drug

NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparti

FORT WORTH, Texas (BUSINESS WIRE) NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle (LSAM) investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.The DDW poster entitled “Intracystic Injecti. ....

China , South-korea , Japan , Canada , Australia , Dan-eramian , Holly-maulhardt , Somashekar-krishna , Shelagh-verco , Opus-biotech-communications , Ohio-state-university-wexner-medical-center , Large-surface-area-microparticle-paclitaxel

HighField Biopharmaceuticals' HF1K16, a New Immuno-Oncology Drug, Shows Promise in Patients with Refractory Glioblastoma | Illinois

HANGZHOU, China (BUSINESS WIRE) May 31, 2023 ....

China , Hangzhou , Zhejiang , Mccormick-place , Illinois , United-states , Chicago , American , Highfield-bio , Donald-wyatt , Yuhong-xu , Dan-eramian

Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov. 10 – 14, in Philadelphia, PA

Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov. 10 – 14, in Philadelphia, PA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Australia , Philadelphia , Pennsylvania , America , William-shi , N-lawrence-edwards , Royj-wu , Dan-eramian , Marc-gurwith , Business-development-contact , Co-ltd